Maxim Group analyst Tom Forte has reiterated their bullish stance on TRAK stock, giving a Buy rating yesterday.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Tom Forte’s rating is based on ReposiTrak’s strategic positioning to benefit from the food industry’s upcoming compliance requirements. Despite the FDA’s traceability mandate being postponed to 2028, major retailers are already pushing for early adoption, which positions ReposiTrak favorably to capture market share with its cloud-based, cost-efficient compliance solutions.
Additionally, ReposiTrak’s financial performance supports the Buy rating. The company reported a 9.7% year-over-year increase in revenue and a 17.2% rise in adjusted EBITDA, surpassing forecasts. With a strong cash position and a competitive P/E multiple below the industry average, ReposiTrak is well-placed for growth, justifying the maintained price target of $29.
In another report released yesterday, TR | OpenAI – 4o also reiterated a Buy rating on the stock with a $16.50 price target.
TRAK’s price has also changed moderately for the past six months – from $22.830 to $15.040, which is a -34.12% drop .